Effect of Inhaled Xenon on Cardiac Function in Comatose Survivors of Out-of-Hospital Cardiac Arrest—A Substudy of the Xenon in Combination With Hypothermia After Cardiac Arrest Trial
OBJECTIVES:. This explorative substudy aimed at determining the effect of inhaled xenon on left ventricular function by echocardiography in comatose survivors of out-of-hospital cardiac arrest. DESIGN:. A randomized two-group single-blinded phase 2 clinical drug trial. SETTING:. A multipurpose ICU i...
Enregistré dans:
Auteurs principaux: | Antti Saraste, MD, PhD, Haitham Ballo, MD, Olli Arola, MD, PhD, Ruut Laitio, MD, PhD, Juhani Airaksinen, MD, PhD, Marja Hynninen, MD, PhD, Minna Bäcklund, MD, PhD, Emmi Ylikoski, MD, PhD, Johanna Wennervirta, MD, PhD, Mikko Pietilä, MD, PhD, Risto O. Roine, MD, PhD, Veli-Pekka Harjola, MD, PhD, Jussi Niiranen, MD, PhD, Kirsi Korpi, MD, PhD, Marjut Varpula, MD, PhD, Harry Scheinin, MD, PhD, Mervyn Maze, MB ChB, Tero Vahlberg, MSc, Timo Laitio, MD, PhD, for the Xe-HYPOTHECA Study Group, Sami Virtanen, Riitta Parkkola, Jani Saunavaara, Juha Martola, Heli Silvennoinen, Marjaana Tiainen, Juha Grönlund, Outi Inkinen, Päivi Silvasti, Eija Nukarinen, Klaus T. Olkkola |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Wolters Kluwer
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/b8323a7599b845a3bff9321226cde503 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Flatline on the alternate vector…Is this subcutaneous implantable cardiac defibrillator lead fractured?
par: Louisa O’Neill, MD, PhD, et autres
Publié: (2021) -
MET Amplification and Efficacy of Nivolumab in Patients With NSCLC
par: Katsuhiro Yoshimura, MD, PhD, et autres
Publié: (2021) -
Fewer Intubations but Higher Mortality Among Intubated Coronavirus Disease 2019 Patients During the Second Than the First Wave
par: Christina Routsi, MD, PhD, et autres
Publié: (2021) -
IL-17A–Mediated Immune-Inflammatory Periarticular Mass and Osteolysis From Impingement in Ceramic-On-Ceramic Total Hip Arthroplasty
par: Tsunehito Ishida, MD, PhD, et autres
Publié: (2021) -
Conversion Surgery for Advanced Thoracic SMARCA4-Deficient Undifferentiated Tumor With Atezolizumab in Combination With Bevacizumab, Paclitaxel, and Carboplatin Treatment: A Case Report
par: Kei Kunimasa, MD, PhD, et autres
Publié: (2021)